To solve the issue of limited penetration depth and overheating of the excited 980 nm near-infrared (NIR) light, and unstable and insufficient loading amount of photosensitizers (PSs) in photodynamic therapy (PDT), we have constructed a well-defined core–shell structured NaGdF 4:Yb/Tm@NaGdF 4:Yb@NaNdF 4:Yb@NaGdF 4 @mSiO 2 @TiO 2 (UCNPs@mSiO 2 @TiO 2 ) nanocomposite by coating a layer of TiO 2 PSs/photocatalyst on an effective 808 nm-to-UV/visible upconversion luminescent (UCL) core to achieve simultaneous multiple bioimaging and efficient PDT. The design of quenching-shield layer can eliminate the back energy transfer from activator Tm 3+ to sensitized Nd 3+, thus significantly improving the UCL emission. The high surface area of mesoporous silica-coated UCNPs facilitates the stable and high loading amount of anatase TiO 2 . In vivo results indicate that 808 nm NIR light-mediated PDT using UCNPs@mSiO 2 @TiO 2 as photosensitizers shows much higher antitumor efficacy than those with 980 nm and UV irradiations due to the higher tissue penetration depth. Meanwhile, the platform itself as an imaging nanoprobe endows the sample with multiple imaging (UCL/CT/MRI) properties. Our work makes great progress toward the integrity of diagnosis and PDT induced by a single 808 nm NIR light.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: